TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy
Age-associated neurodegenerative disorders demonstrating tau-laden intracellular inclusions are known as tauopathies. We previously linked a loss-of-function mutation in the gene to tau accumulation and frontotemporal lobar degeneration. Now, we have identified genetic variants in that decrease TSC1...
Gespeichert in:
Veröffentlicht in: | Science advances 2021-11, Vol.7 (45), p.eabg3897-eabg3897 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | eabg3897 |
---|---|
container_issue | 45 |
container_start_page | eabg3897 |
container_title | Science advances |
container_volume | 7 |
creator | Alquezar, Carolina Schoch, Kathleen M Geier, Ethan G Ramos, Eliana Marisa Scrivo, Aurora Li, Kathy H Argouarch, Andrea R Mlynarski, Elisabeth E Dombroski, Beth DeTure, Michael Dickson, Dennis W Yokoyama, Jennifer S Cuervo, Ana M Burlingame, Alma L Schellenberg, Gerard D Miller, Timothy M Miller, Bruce L Kao, Aimee W |
description | Age-associated neurodegenerative disorders demonstrating tau-laden intracellular inclusions are known as tauopathies. We previously linked a loss-of-function mutation in the
gene to tau accumulation and frontotemporal lobar degeneration. Now, we have identified genetic variants in
that decrease TSC1/hamartin levels and predispose to tauopathies such as Alzheimer’s disease and progressive supranuclear palsy. Cellular and murine models of
haploinsufficiency, as well as human brains carrying a
risk variant, accumulated tau protein that exhibited aberrant acetylation. This acetylation hindered tau degradation via chaperone-mediated autophagy, thereby leading to its accumulation. Aberrant tau acetylation in
haploinsufficiency resulted from the dysregulation of both p300 acetyltransferase and SIRT1 deacetylase. Pharmacological modulation of either enzyme restored tau levels. This study substantiates
as a novel tauopathy risk gene and includes
haploinsufficiency as a genetic model for tauopathies. In addition, these findings promote tau acetylation as a rational target for tauopathy therapeutics and diagnostic. |
doi_str_mv | 10.1126/sciadv.abg3897 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8570595</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2594291609</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-6758397bf9bb164cb9fb4d2448ddafe520f9961be5a96c6f27f120c5340424173</originalsourceid><addsrcrecordid>eNpVUU1v1DAQjRCIVqVXjshHLtn6O_EFCa0oIFXiQDlbY8feNWTtYDsr5dafTqrdVuU0o3lv3jzNa5r3BG8IofKm2ADDcQNmx3rVvWouKetESwXvX7_oL5rrUn5jjAmXUhD1trlgvGOKYXXZPNz_3BI0plJQiDY7KK6gHMof5FNGFeY0Qd0vyCwrPsw2xN3jFIF1dRmhhhQRxAFN2R1drE-wHR1kiNahYwBk9zC5nKJrD24IUN2AYK5p2sNuede88TAWd32uV82v2y_322_t3Y-v37ef71rLFK6t7ETPVGe8MoZIbo3yhg-U834YwDtBsVdKEuMEKGmlp50nFFvBOOaUk45dNZ9OutNsVhd2NZth1FMOB8iLThD0_0gMe71LR92LDgslVoGPZ4Gc_s6uVH0IxbpxhOjSXDQVilNFJFYrdXOi2rw-Njv_fIZg_ZicPiWnz8mtCx9emnumP-XE_gGz15oG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2594291609</pqid></control><display><type>article</type><title>TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Alquezar, Carolina ; Schoch, Kathleen M ; Geier, Ethan G ; Ramos, Eliana Marisa ; Scrivo, Aurora ; Li, Kathy H ; Argouarch, Andrea R ; Mlynarski, Elisabeth E ; Dombroski, Beth ; DeTure, Michael ; Dickson, Dennis W ; Yokoyama, Jennifer S ; Cuervo, Ana M ; Burlingame, Alma L ; Schellenberg, Gerard D ; Miller, Timothy M ; Miller, Bruce L ; Kao, Aimee W</creator><creatorcontrib>Alquezar, Carolina ; Schoch, Kathleen M ; Geier, Ethan G ; Ramos, Eliana Marisa ; Scrivo, Aurora ; Li, Kathy H ; Argouarch, Andrea R ; Mlynarski, Elisabeth E ; Dombroski, Beth ; DeTure, Michael ; Dickson, Dennis W ; Yokoyama, Jennifer S ; Cuervo, Ana M ; Burlingame, Alma L ; Schellenberg, Gerard D ; Miller, Timothy M ; Miller, Bruce L ; Kao, Aimee W</creatorcontrib><description>Age-associated neurodegenerative disorders demonstrating tau-laden intracellular inclusions are known as tauopathies. We previously linked a loss-of-function mutation in the
gene to tau accumulation and frontotemporal lobar degeneration. Now, we have identified genetic variants in
that decrease TSC1/hamartin levels and predispose to tauopathies such as Alzheimer’s disease and progressive supranuclear palsy. Cellular and murine models of
haploinsufficiency, as well as human brains carrying a
risk variant, accumulated tau protein that exhibited aberrant acetylation. This acetylation hindered tau degradation via chaperone-mediated autophagy, thereby leading to its accumulation. Aberrant tau acetylation in
haploinsufficiency resulted from the dysregulation of both p300 acetyltransferase and SIRT1 deacetylase. Pharmacological modulation of either enzyme restored tau levels. This study substantiates
as a novel tauopathy risk gene and includes
haploinsufficiency as a genetic model for tauopathies. In addition, these findings promote tau acetylation as a rational target for tauopathy therapeutics and diagnostic.</description><identifier>ISSN: 2375-2548</identifier><identifier>EISSN: 2375-2548</identifier><identifier>DOI: 10.1126/sciadv.abg3897</identifier><identifier>PMID: 34739309</identifier><language>eng</language><publisher>United States: American Association for the Advancement of Science</publisher><subject>Cellular Neuroscience ; Neuroscience ; SciAdv r-articles</subject><ispartof>Science advances, 2021-11, Vol.7 (45), p.eabg3897-eabg3897</ispartof><rights>Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). 2021 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-6758397bf9bb164cb9fb4d2448ddafe520f9961be5a96c6f27f120c5340424173</citedby><cites>FETCH-LOGICAL-c390t-6758397bf9bb164cb9fb4d2448ddafe520f9961be5a96c6f27f120c5340424173</cites><orcidid>0000-0003-1115-2475 ; 0000-0002-8403-7307 ; 0000-0002-3424-5511 ; 0000-0001-7189-7917 ; 0000-0002-6560-2876 ; 0000-0002-4363-1262 ; 0000-0002-2152-4220 ; 0000-0002-7686-7968 ; 0000-0002-7602-3108 ; 0000-0002-0970-4894 ; 0000-0002-5334-1306 ; 0000-0002-0771-700X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570595/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570595/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34739309$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alquezar, Carolina</creatorcontrib><creatorcontrib>Schoch, Kathleen M</creatorcontrib><creatorcontrib>Geier, Ethan G</creatorcontrib><creatorcontrib>Ramos, Eliana Marisa</creatorcontrib><creatorcontrib>Scrivo, Aurora</creatorcontrib><creatorcontrib>Li, Kathy H</creatorcontrib><creatorcontrib>Argouarch, Andrea R</creatorcontrib><creatorcontrib>Mlynarski, Elisabeth E</creatorcontrib><creatorcontrib>Dombroski, Beth</creatorcontrib><creatorcontrib>DeTure, Michael</creatorcontrib><creatorcontrib>Dickson, Dennis W</creatorcontrib><creatorcontrib>Yokoyama, Jennifer S</creatorcontrib><creatorcontrib>Cuervo, Ana M</creatorcontrib><creatorcontrib>Burlingame, Alma L</creatorcontrib><creatorcontrib>Schellenberg, Gerard D</creatorcontrib><creatorcontrib>Miller, Timothy M</creatorcontrib><creatorcontrib>Miller, Bruce L</creatorcontrib><creatorcontrib>Kao, Aimee W</creatorcontrib><title>TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy</title><title>Science advances</title><addtitle>Sci Adv</addtitle><description>Age-associated neurodegenerative disorders demonstrating tau-laden intracellular inclusions are known as tauopathies. We previously linked a loss-of-function mutation in the
gene to tau accumulation and frontotemporal lobar degeneration. Now, we have identified genetic variants in
that decrease TSC1/hamartin levels and predispose to tauopathies such as Alzheimer’s disease and progressive supranuclear palsy. Cellular and murine models of
haploinsufficiency, as well as human brains carrying a
risk variant, accumulated tau protein that exhibited aberrant acetylation. This acetylation hindered tau degradation via chaperone-mediated autophagy, thereby leading to its accumulation. Aberrant tau acetylation in
haploinsufficiency resulted from the dysregulation of both p300 acetyltransferase and SIRT1 deacetylase. Pharmacological modulation of either enzyme restored tau levels. This study substantiates
as a novel tauopathy risk gene and includes
haploinsufficiency as a genetic model for tauopathies. In addition, these findings promote tau acetylation as a rational target for tauopathy therapeutics and diagnostic.</description><subject>Cellular Neuroscience</subject><subject>Neuroscience</subject><subject>SciAdv r-articles</subject><issn>2375-2548</issn><issn>2375-2548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVUU1v1DAQjRCIVqVXjshHLtn6O_EFCa0oIFXiQDlbY8feNWTtYDsr5dafTqrdVuU0o3lv3jzNa5r3BG8IofKm2ADDcQNmx3rVvWouKetESwXvX7_oL5rrUn5jjAmXUhD1trlgvGOKYXXZPNz_3BI0plJQiDY7KK6gHMof5FNGFeY0Qd0vyCwrPsw2xN3jFIF1dRmhhhQRxAFN2R1drE-wHR1kiNahYwBk9zC5nKJrD24IUN2AYK5p2sNuede88TAWd32uV82v2y_322_t3Y-v37ef71rLFK6t7ETPVGe8MoZIbo3yhg-U834YwDtBsVdKEuMEKGmlp50nFFvBOOaUk45dNZ9OutNsVhd2NZth1FMOB8iLThD0_0gMe71LR92LDgslVoGPZ4Gc_s6uVH0IxbpxhOjSXDQVilNFJFYrdXOi2rw-Njv_fIZg_ZicPiWnz8mtCx9emnumP-XE_gGz15oG</recordid><startdate>20211105</startdate><enddate>20211105</enddate><creator>Alquezar, Carolina</creator><creator>Schoch, Kathleen M</creator><creator>Geier, Ethan G</creator><creator>Ramos, Eliana Marisa</creator><creator>Scrivo, Aurora</creator><creator>Li, Kathy H</creator><creator>Argouarch, Andrea R</creator><creator>Mlynarski, Elisabeth E</creator><creator>Dombroski, Beth</creator><creator>DeTure, Michael</creator><creator>Dickson, Dennis W</creator><creator>Yokoyama, Jennifer S</creator><creator>Cuervo, Ana M</creator><creator>Burlingame, Alma L</creator><creator>Schellenberg, Gerard D</creator><creator>Miller, Timothy M</creator><creator>Miller, Bruce L</creator><creator>Kao, Aimee W</creator><general>American Association for the Advancement of Science</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1115-2475</orcidid><orcidid>https://orcid.org/0000-0002-8403-7307</orcidid><orcidid>https://orcid.org/0000-0002-3424-5511</orcidid><orcidid>https://orcid.org/0000-0001-7189-7917</orcidid><orcidid>https://orcid.org/0000-0002-6560-2876</orcidid><orcidid>https://orcid.org/0000-0002-4363-1262</orcidid><orcidid>https://orcid.org/0000-0002-2152-4220</orcidid><orcidid>https://orcid.org/0000-0002-7686-7968</orcidid><orcidid>https://orcid.org/0000-0002-7602-3108</orcidid><orcidid>https://orcid.org/0000-0002-0970-4894</orcidid><orcidid>https://orcid.org/0000-0002-5334-1306</orcidid><orcidid>https://orcid.org/0000-0002-0771-700X</orcidid></search><sort><creationdate>20211105</creationdate><title>TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy</title><author>Alquezar, Carolina ; Schoch, Kathleen M ; Geier, Ethan G ; Ramos, Eliana Marisa ; Scrivo, Aurora ; Li, Kathy H ; Argouarch, Andrea R ; Mlynarski, Elisabeth E ; Dombroski, Beth ; DeTure, Michael ; Dickson, Dennis W ; Yokoyama, Jennifer S ; Cuervo, Ana M ; Burlingame, Alma L ; Schellenberg, Gerard D ; Miller, Timothy M ; Miller, Bruce L ; Kao, Aimee W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-6758397bf9bb164cb9fb4d2448ddafe520f9961be5a96c6f27f120c5340424173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cellular Neuroscience</topic><topic>Neuroscience</topic><topic>SciAdv r-articles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alquezar, Carolina</creatorcontrib><creatorcontrib>Schoch, Kathleen M</creatorcontrib><creatorcontrib>Geier, Ethan G</creatorcontrib><creatorcontrib>Ramos, Eliana Marisa</creatorcontrib><creatorcontrib>Scrivo, Aurora</creatorcontrib><creatorcontrib>Li, Kathy H</creatorcontrib><creatorcontrib>Argouarch, Andrea R</creatorcontrib><creatorcontrib>Mlynarski, Elisabeth E</creatorcontrib><creatorcontrib>Dombroski, Beth</creatorcontrib><creatorcontrib>DeTure, Michael</creatorcontrib><creatorcontrib>Dickson, Dennis W</creatorcontrib><creatorcontrib>Yokoyama, Jennifer S</creatorcontrib><creatorcontrib>Cuervo, Ana M</creatorcontrib><creatorcontrib>Burlingame, Alma L</creatorcontrib><creatorcontrib>Schellenberg, Gerard D</creatorcontrib><creatorcontrib>Miller, Timothy M</creatorcontrib><creatorcontrib>Miller, Bruce L</creatorcontrib><creatorcontrib>Kao, Aimee W</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Science advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alquezar, Carolina</au><au>Schoch, Kathleen M</au><au>Geier, Ethan G</au><au>Ramos, Eliana Marisa</au><au>Scrivo, Aurora</au><au>Li, Kathy H</au><au>Argouarch, Andrea R</au><au>Mlynarski, Elisabeth E</au><au>Dombroski, Beth</au><au>DeTure, Michael</au><au>Dickson, Dennis W</au><au>Yokoyama, Jennifer S</au><au>Cuervo, Ana M</au><au>Burlingame, Alma L</au><au>Schellenberg, Gerard D</au><au>Miller, Timothy M</au><au>Miller, Bruce L</au><au>Kao, Aimee W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy</atitle><jtitle>Science advances</jtitle><addtitle>Sci Adv</addtitle><date>2021-11-05</date><risdate>2021</risdate><volume>7</volume><issue>45</issue><spage>eabg3897</spage><epage>eabg3897</epage><pages>eabg3897-eabg3897</pages><issn>2375-2548</issn><eissn>2375-2548</eissn><abstract>Age-associated neurodegenerative disorders demonstrating tau-laden intracellular inclusions are known as tauopathies. We previously linked a loss-of-function mutation in the
gene to tau accumulation and frontotemporal lobar degeneration. Now, we have identified genetic variants in
that decrease TSC1/hamartin levels and predispose to tauopathies such as Alzheimer’s disease and progressive supranuclear palsy. Cellular and murine models of
haploinsufficiency, as well as human brains carrying a
risk variant, accumulated tau protein that exhibited aberrant acetylation. This acetylation hindered tau degradation via chaperone-mediated autophagy, thereby leading to its accumulation. Aberrant tau acetylation in
haploinsufficiency resulted from the dysregulation of both p300 acetyltransferase and SIRT1 deacetylase. Pharmacological modulation of either enzyme restored tau levels. This study substantiates
as a novel tauopathy risk gene and includes
haploinsufficiency as a genetic model for tauopathies. In addition, these findings promote tau acetylation as a rational target for tauopathy therapeutics and diagnostic.</abstract><cop>United States</cop><pub>American Association for the Advancement of Science</pub><pmid>34739309</pmid><doi>10.1126/sciadv.abg3897</doi><orcidid>https://orcid.org/0000-0003-1115-2475</orcidid><orcidid>https://orcid.org/0000-0002-8403-7307</orcidid><orcidid>https://orcid.org/0000-0002-3424-5511</orcidid><orcidid>https://orcid.org/0000-0001-7189-7917</orcidid><orcidid>https://orcid.org/0000-0002-6560-2876</orcidid><orcidid>https://orcid.org/0000-0002-4363-1262</orcidid><orcidid>https://orcid.org/0000-0002-2152-4220</orcidid><orcidid>https://orcid.org/0000-0002-7686-7968</orcidid><orcidid>https://orcid.org/0000-0002-7602-3108</orcidid><orcidid>https://orcid.org/0000-0002-0970-4894</orcidid><orcidid>https://orcid.org/0000-0002-5334-1306</orcidid><orcidid>https://orcid.org/0000-0002-0771-700X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2375-2548 |
ispartof | Science advances, 2021-11, Vol.7 (45), p.eabg3897-eabg3897 |
issn | 2375-2548 2375-2548 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8570595 |
source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Cellular Neuroscience Neuroscience SciAdv r-articles |
title | TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A27%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TSC1%20loss%20increases%20risk%20for%20tauopathy%20by%20inducing%20tau%20acetylation%20and%20preventing%20tau%20clearance%20via%20chaperone-mediated%20autophagy&rft.jtitle=Science%20advances&rft.au=Alquezar,%20Carolina&rft.date=2021-11-05&rft.volume=7&rft.issue=45&rft.spage=eabg3897&rft.epage=eabg3897&rft.pages=eabg3897-eabg3897&rft.issn=2375-2548&rft.eissn=2375-2548&rft_id=info:doi/10.1126/sciadv.abg3897&rft_dat=%3Cproquest_pubme%3E2594291609%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2594291609&rft_id=info:pmid/34739309&rfr_iscdi=true |